Prevalence of HCV Infection Among Hemodialysis Patients in Lanzhou of Northwestern China

References

• Thrift AP, El-Serag HB, Kanwal F. Global epidemiology and burden of HCV infection and HCV-related disease. Nat Rev Gastroenterol Hepatol. 2017;14:122–132. doi:10.1038/nrgastro.2016.176
   PubMed Web of Science ®Google Scholar
• World Health Organization. Global hepatitis report; 2017. Available from: https://www.who.int/publications/i/item/9789241565455. Accessed July 24, 2022.
   Google Scholar
• World Health Organization. Fact sheets, Hepatitis C; 2022. Available from: https://www.who.int/news-room/fact-sheets/detail/hepatitis-C. Accessed September 17,2022.
   Google Scholar
• Spearman CW, Dusheiko GM, Hellard M, et al. Hepatitis C. Lancet. 2019;394:1452–1466. doi:10.1016/S0140-6736(19)32320-7
   Web of Science ®Google Scholar
• Shergill R, Syed W, Rizvi SA, et al. Nutritional support in chronic liver disease and cirrhotics. World J Hepatol. 2018;10:685–694. doi:10.4254/wjh.v10.i10.685
   Web of Science ®Google Scholar
• Tsiakalos A, Voumvas T, Psarris A, et al. Circulating autoantibodies to endogenous erythropoietin are associated with chronic hepatitis C virus infection-related anemia. Hepatobiliary Pancreat Dis Int. 2017;16:289–295. doi:10.1016/s1499-3872(16)60131-5
   Web of Science ®Google Scholar
• Rahnavardi M, Hosseini Moghaddam SM, Alavian SM. Hepatitis C in hemodialysis patients: current global magnitude, natural history, diagnostic difficulties, and preventive measures. Am J Nephrol. 2008;28:628–640. doi:10.1159/000117573
   PubMed Web of Science ®Google Scholar
• Silva LK, Silva MB, Rodart IF, et al. Prevalence of hepatitis C virus (HCV) infection and HCV genotypes of hemodialysis patients in Salvador, Northeastern Brazil. Braz J Med Biol Res. 2006;39:595–602. doi:10.1590/s0100-879x2006000500005
   Web of Science ®Google Scholar
• Ashkani ES, Alavian SM, Salehi MM. Prevalence of hepatitis C virus infection among hemodialysis patients in the Middle-East: a systematic review and meta-analysis. World J Gastroenterol. 2017;23:151–166. doi:10.3748/wjg.v23.i1.151
   Web of Science ®Google Scholar
• Malhotra R, Soin D, Grover P, et al. Hepatitis B virus and hepatitis C virus co-infection in hemodialysis patients: a retrospective study from a tertiary care hospital of North India. J Nat Sci Biol Med. 2016;7:72–74. doi:10.4103/0976-9668.175076
   PubMedGoogle Scholar
• Söderholm J, Millbourn C, Büsch K, et al. Higher risk of renal disease in chronic hepatitis C patients: antiviral therapy survival benefit in patients on hemodialysis. J Hepatol. 2018;68:904–911. doi:10.1016/j.jhep.2017.12.003
   PubMed Web of Science ®Google Scholar
• Jadoul M, Bieber BA, Martin P, et al. Prevalence, incidence, and risk factors for hepatitis C virus infection in hemodialysis patients. Kidney Int. 2019;95:939–947. doi:10.1016/j.kint.2018.11.038
   PubMed Web of Science ®Google Scholar
• Gómez-Gutiérrez C, Chávez-Tapia NC, Ponciano-Rodríguez G, Uribe M, Méndez-Sánchez N. Prevalence of hepatitis C virus infection among patients undergoing haemodialysis in Latin America. Ann Hepatol. 2015;14:807–814. doi:10.5604/16652681.1171751
   Web of Science ®Google Scholar
• Petruzziello A, Coppola N, Loquercio G, et al. Distribution pattern of hepatitis C virus genotypes and correlation with viral load and risk factors in chronic positive patients. Intervirology. 2014;57:311–318. doi:10.1159/000363386
   Web of Science ®Google Scholar
• Ding GW, Ye SD, Hei FX, et al. Sentinel surveillance for viral hepatitis C in China, 2016–2017. Chinese. Chin J Epidemiol. 2019;40:41–45. doi:10.3760/cma.j.issn.0254-6450.2019.01.009
   Google Scholar
• Pan Y, Zheng Y, Qin T, et al. Disease progression in Chinese patients with hepatitis C virus RNA-positive infection via blood transfusion. Exp Ther Med. 2016;12:3476–3484. doi:10.3892/etm.2016.3792
   Web of Science ®Google Scholar
• Guss D, Sherigar J, Rosen P, et al. Diagnosis and management of hepatitis C infection in primary care settings. J Gen Intern Med. 2018;33(4):551–557. doi:10.1007/s11606-017-4280-y
   Web of Science ®Google Scholar
• Gao Y, Yang J, Sun F, et al. Prevalence of anti-HCV antibody among the general population in mainland china between 1991 and 2015: a systematic review and meta-analysis. Open Forum Infect Dis. 2019;6:888–891. doi:10.1093/ofid/ofz040
   Web of Science ®Google Scholar
• Caragea DC, Mihailovici AR, Streba CT, et al. Hepatitis C infection in hemodialysis patients. Curr Health Sci J. 2018;44:107–112. doi:10.12865/CHSJ.44.02.02
   Google Scholar
• Chapman JR. The KDIGO clinical practice guidelines for the care of kidney transplant. Transplantation. 2010;89:644–645. doi:10.1097/TP.0b013e3181d62f1b
   PubMed Web of Science ®Google Scholar
• Goodkin DA, Bieber B, Jadoul M, et al. Mortality, hospitalization, and quality of life among patients with hepatitis C infection on hemodialysis. Clinical J Am Soc Nephrol. 2017;12:287–297. doi:10.2215/CJN.07940716
   PubMed Web of Science ®Google Scholar
• Pereira BJ, Levey AS. Hepatitis C virus infection in dialysis and renal transplantation. Kidney Int. 1997;51(4):981–999. doi:10.1038/ki.1997.139
   PubMed Web of Science ®Google Scholar
• Hayashi J, Yoshimura E, Nabeshima A, et al. Seroepidemiology of hepatitis C virus infection in hemodialysis patients and the general population in Fukuoka and Okinawa, Japan. J Gastroenterol. 1994;29:276–281. doi:10.1007/BF02358365
   PubMed Web of Science ®Google Scholar
• Gao X, Cui Q, Shi X, et al. Prevalence and trend of hepatitis C virus infection among blood donors in Chinese mainland: a systematic review and meta-analysis. BMC Infect Dis. 2011;11:88. doi:10.1186/1471-2334-11-88
   Web of Science ®Google Scholar
• Liu YB, Xie JZ, Zhong CJ, et al. Hepatitis C virus infection among hemodialysis patients in Asia: a meta-analysis. Eur Rev Med Pharmacol Sci. 2014;18:3174–3182.
   Web of Science ®Google Scholar
• Su Y, Yan R, Duan Z, et al. Prevalence and risk factors of hepatitis C and B virus infections in hemodialysis patients and their spouses: a multicenter study in Beijing, China. J Med Virol. 2013;85:425–432. doi:10.1002/jmv.23486
   Web of Science ®Google Scholar
• Jakupi X, Mlakar J, Lunar MM, et al. A very high prevalence of hepatitis C virus infection among patients undergoing hemodialysis in Kosovo: a nationwide study. BMC Nephrol. 2018;19:304–312. doi:10.1186/s12882-018-1100-5
   Web of Science ®Google Scholar
• Hinrichsen H, Leimenstoll G, Stegen G, et al. Prevalence and risk factors of hepatitis C virus infection in haemodialysis patients: a multicentre study in 2796 patients. Gut. 2002;51(3):429–433. doi:10.1136/gut.51.3.429
   PubMed Web of Science ®Google Scholar
• Van Remoortel H, Moorkens D, Avau B, Compernolle V, Vandekerckhove P, De Buck E. Is there a risk of transfusion-transmissible infections after percutaneous needle treatments in blood donors? A systematic review and meta-analysis. Vox Sang. 2019;114:297–309. doi:10.1111/vox.12780
   Web of Science ®Google Scholar
• Vidales-Braz BM, da Silva NM, Lobato R, et al. Detection of hepatitis C virus in patients with terminal renal disease undergoing dialysis in southern Brazil: prevalence, risk factors, genotypes, and viral load dynamics in hemodialysis patients. Virol J. 2015;12:8. doi:10.1186/s12985-015-0238-z
   PubMed Web of Science ®Google Scholar
• Carrero J. Gender differences in chronic kidney disease: underpinnings and therapeutic implications. Kidney Blood Press Res. 2010;33:383–392. doi:10.1159/000320389
   PubMed Web of Science ®Google Scholar
• Cobo G, Hecking M, Port FK, et al. Sex and gender differences in chronic kidney disease: progression to end-stage renal disease and haemodialysis. Clin Sci. 2016;130:1147–1163. doi:10.1042/CS20160047
   PubMed Web of Science ®Google Scholar
• Carrero J, Hecking M, Chesnaye NC, Jager KJ. Sex and gender disparities in the epidemiology and outcomes of chronic kidney disease. Nat Rev Nephrol. 2018;14:151–164. doi:10.1038/nrneph.2017.181
   PubMed Web of Science ®Google Scholar